Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies

BACKGROUND: The risk of cancer, including any secular trends in risk, in patients with juvenile idiopathic arthritis (JIA) is incompletely understood. METHODS: We performed a register-based cohort study of patients with JIA from 2001 until 2017, identified via the Swedish Patient Register. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Horne, AnnaCarin, Delcoigne, Bénédicte, Palmblad, Karin, Askling, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatric Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861063/
https://www.ncbi.nlm.nih.gov/pubmed/31798956
http://dx.doi.org/10.1136/rmdopen-2019-001055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861063/
https://www.ncbi.nlm.nih.gov/pubmed/31798956
http://dx.doi.org/10.1136/rmdopen-2019-001055

Ejemplares similares